Live healthier, stronger and sharper for longer
Short, frequent pieces on what changed in the science of ageing well — and our research library holds the deep dives.
PeptidesSS-31 (Elamipretide) in 2026: Latest Clinical
A deep dive into SS-31 (Elamipretide)'s most recent clinical findings, focusing on 2025-2026 data and its implications for longevity and healthspan.
PeptidesSS-31 (Elamipretide): Latest Evidence and 2026
Explore the cutting-edge science behind SS-31 (Elamipretide), with a focus on breakthroughs from 2025-2026 and its potential in healthy ageing.
PeptidesIpamorelin in the UK: Availability, Cost, and
Demystifying Ipamorelin's landscape in the UK, this post offers a comprehensive guide to its availability, pricing, legal status, and reputable sourcing channels for 2026.
PeptidesSS-31 (Elamipretide) in 2026: Unpacking the
SS-31 (Elamipretide) continues to garner attention for its mitochondrial-targeting properties. We delve into the newest clinical data and revised insights for 2026.
PeptidesSS-31 (Elamipretide) Latest Evidence 2026: A
This updated review focuses on the latest 2025-2026 evidence for SS-31 (Elamipretide), dissecting new clinical trials and their implications for longevity and mitochondrial health.
PeptidesSS-31 Dosing & Protocol Optimisation for
Demystifying SS-31 dosing is crucial for maximising its mitochondrial benefits. We break down protocols for longevity, performance, and recovery, informed by the latest research.
Wondering where to start?
Two minutes, no blood test, no sign-up — find out how you are actually ageing, and what to do about it.
The Sunday briefing
One email a week: what changed in the evidence, what it means for the markers you track, and the occasional thing worth stopping. No spam, unsubscribe anytime.